WORLDWIDE CONTACT US ABOUT US INVENTING FOR LIFE PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home EXECUTIVE COMMITTEE Kenneth C. Frazier Chairman of the Board and Chief Executive Officer Chairman of the board and chief executive officer, Merck & Co., Inc., 2011 President, Merck & Co., Inc., 2010 Executive vice president and president, Global Human Health, Merck & Co., Inc., 2007-2010 Executive vice president and general counsel, Merck & Co., Inc., 2006-2007 Senior vice president and general counsel, Merck & Co., Inc., 1999-2006 Read bio Sanat Chattopadhyay Executive Vice President and President, Merck Manufacturing Division Executive vice president and president, Merck Manufacturing Division, 2016 Senior vice president, Operations, Merck Manufacturing Division, 2009-2016 Senior vice president, New Products & Process Development, Wyeth Pharmaceuticals 2007-2009 Vice president, Technical Operations & Product Supply, Wyeth Pharmaceuticals, 2005-2007 Senior vice president, Product Development & Supply, Aventis Pharmaceuticals, 2003-2005 Robert M. Davis Executive Vice President, Global Services, and Chief Financial Officer Executive vice president, Global Services, and chief financial officer, Merck & Co., Inc., 2016 Executive vice president and chief financial officer, Merck & Co., Inc., 2014-2016 Corporate vice president and president, Baxter Medical Products, 2010-2014 Corporate vice president and chief financial officer, Baxter Healthcare, 2006-2010; treasurer, Baxter Healthcare, 2004-2006; Director of Corporate Financial Planning, Eli Lilly and Company, 2002-2004; assistant treasurer and various financial positions, Eli Lilly and Company, 1990-2002 Richard R. DeLuca Jr. Executive Vice President and President, Merck Animal Health Executive vice president and president, Merck Animal Health, 2011 Chief financial officer, Becton Dickinson Biosciences, 2010-2011 President, Wyeth's Fort Dodge Animal Health division, 2007-2010 Chief operating officer, Fort Dodge, 2006-2007; executive vice president and chief financial officer, 2002-2006 Vice president, Finance, Wyeth Pharmaceuticals, 1998-2002 Julie L. Gerberding, M.D., M.P.H. Executive Vice President & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health Executive vice president & chief patient officer, Strategic Communications, Global Public Policy and Population Health, Merck & Co., Inc., 2016 President, Merck Vaccines, 2010-2014 Co-Chair, Board of Directors, Sanofi Pasteur MSD Joint Venture, 2010-present Director, Centers for Disease Control and Prevention (CDC), 2002-2009 Director, Division of Healthcare Quality Promotion, CDC, 1998-2002 Adjunct Associate Clinical Professor of Medicine in Infectious Disease, University of California, San Francisco, 2002-present Mirian M. Graddick-Weir Executive Vice President, Human Resources Executive vice president, Human Resources, Merck & Co., Inc., 2008 Senior vice president, Human Resources, Merck & Co., Inc., 2006-2007 Executive vice president, Human Resources and Employee Communications, AT&T, 2004-2006 Executive vice president, Human Resources, AT&T, 1999-2004 Chief human resources officer, Consumer Services Company, AT&T, 1998-1999 Roger M. Perlmutter, M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories Executive vice president and president, Merck Research Laboratories, 2013 Executive vice president and head of Research and Development, Amgen Inc., 2001-2012 Executive vice president of Worldwide Basic Research and Preclinical Development, Merck Research Laboratories, 1998-2001; senior vice president, Merck Research Laboratories, 1997-1998 Professor, Departments of Immunology, Biochemistry and Medicine, University of Washington, 1991-1997 Adam H. Schechter Executive Vice President and President, Global Human Health Executive vice president and president, Global Human Health, Merck & Co., Inc., 2010 President, Global Pharmaceuticals, 2007-2010 and Integration Officer, Merck & Co., Inc., 2009-2010 President, U.S. Human Health, Merck & Co., Inc., 2006-2007 Senior vice president and general manager, U.S. Osteoporosis, Respiratory and Neuroscience, Merck & Co., Inc., 2005-2006 Jennifer Zachary Executive Vice President and General Counsel Executive vice president and general counsel, Merck & Co., Inc., 2018 Partner, Covington & Burling LLP, 2013-2018; Associate, Covington & Burling LLP, 2011-2013; U.S. Food and Drug Administration, Associate Chief Counsel for Enforcement, 2005-2011 U.S. Attorney’s Office for the District of Columbia, Civil Division, Special Assistant U.S. Attorney, 2009 CODE OF CONDUCT: OUR VALUES AND STANDARDS Our code of conduct reflects our corporate values and guides our day-to-day decision making. Learn more Copyright. © 2009-2018 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map